Vertex Pharmaceuticals Incorporated
VRTX
$472.75
-$5.15-1.08%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.05% | -3.64% | 10.13% | -39.03% | -45.48% |
| Total Receivables | 27.55% | 11.18% | 14.33% | 0.66% | 2.94% |
| Inventory | 39.94% | 50.66% | 63.93% | 67.22% | 63.16% |
| Prepaid Expenses | 60.32% | 58.31% | 21.08% | 22.86% | -14.58% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -43.29% | 41.90% | -73.56% | 62.33% | 139.84% |
| Total Current Assets | 16.72% | 7.81% | 16.62% | -24.68% | -32.15% |
|
|
|||||
| Total Current Assets | 16.72% | 7.81% | 16.62% | -24.68% | -32.15% |
| Net Property, Plant & Equipment | 19.28% | 20.01% | 49.60% | 77.32% | 77.89% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -48.64% | -48.32% | -48.00% | -47.16% | -1.67% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 24.11% | 22.60% | 23.48% | 26.14% | 20.62% |
| Total Assets | 13.80% | 11.79% | 19.39% | -4.34% | -0.87% |
|
|
|||||
| Total Accounts Payable | 11.79% | 6.19% | 34.89% | 26.64% | 13.18% |
| Total Accrued Expenses | 9.16% | 12.23% | 11.25% | 5.58% | 2.81% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -10.29% | -- | -- | -- | 10.27% |
| Total Finance Division Other Current Liabilities | 3.89% | 54.16% | 52.31% | -40.43% | -20.48% |
| Total Other Current Liabilities | 3.89% | 54.16% | 52.31% | -40.43% | -20.48% |
| Total Current Liabilities | 8.32% | 12.64% | 16.67% | -0.33% | 0.48% |
|
|
|||||
| Total Current Liabilities | 8.32% | 12.64% | 16.67% | -0.33% | 0.48% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 17.86% | 7.75% | 63.64% | 128.63% | 128.67% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 28.94% | 32.15% | 36.35% | 11.52% | 2.75% |
| Total Liabilities | 13.94% | 14.13% | 28.07% | 18.87% | 18.91% |
|
|
|||||
| Common Stock & APIC | -23.27% | -27.41% | -15.67% | -15.26% | -10.43% |
| Retained Earnings | 41.15% | 42.27% | 47.56% | -8.80% | -5.28% |
| Treasury Stock & Other | -112.44% | -323.96% | -549.33% | 293.64% | 993.71% |
| Total Common Equity | 13.75% | 10.80% | 16.25% | -11.05% | -6.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.75% | 10.80% | 16.25% | -11.05% | -6.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.75% | 10.80% | 16.25% | -11.05% | -6.66% |
|
|
|||||